134 related articles for article (PubMed ID: 4314784)
1. [Status of the therapy of multiple sclerosis].
Bas H
Ther Ggw; 1967 Oct; 106(10):1319-25. PubMed ID: 4314784
[No Abstract] [Full Text] [Related]
2. [Multiple sclerosis].
Carafa M
Minerva Med; 1976 Sep; 67(46):2997-3005. PubMed ID: 184403
[No Abstract] [Full Text] [Related]
3. [Personal experiences with myotonolytics].
Vurdelja N; Orovcanec K
Med Pregl; 1969; 22(5-6):263-6. PubMed ID: 5396216
[No Abstract] [Full Text] [Related]
4. [Treatment of disseminated sclerosis with Bogomolet's serum].
NIKOEVSKI P; TEPTSIEVA M; RUSKOVA T
Suvr Med (Sofiia); 1957; 8(12):104-9. PubMed ID: 13569151
[No Abstract] [Full Text] [Related]
5. Treatment of vascular diseases with Mydocalm.
Sztankay C
Ther Hung; 1970; 18(3):121-4. PubMed ID: 5496813
[No Abstract] [Full Text] [Related]
6. [Management of multiple sclerosis].
Jerusalem F
Schweiz Med Wochenschr; 1968 Nov; 98(48):1907-8. PubMed ID: 4303139
[No Abstract] [Full Text] [Related]
7. Comparative effects of muscle relaxants and occlusal bite plate in treatment of temporomandibular joint dysfunction syndrome.
Amir A; Sakuda M; Miyazaki T
J Osaka Univ Dent Sch; 1978 Dec; 18():1-10. PubMed ID: 296264
[No Abstract] [Full Text] [Related]
8. Utilization of the myorelaxant action of mydocalm in the clinical practice.
Perényi G
Ther Hung; 1978; 26(3):107-10. PubMed ID: 725813
[No Abstract] [Full Text] [Related]
9. [Peripheral vascular diseases and generalized scleroderma treated with mydocalm].
Lukasiak B; Szczepański A; Rózański J; Wnorowski J
Przegl Dermatol; 1973; 60(3):383-9. PubMed ID: 4748081
[No Abstract] [Full Text] [Related]
10. [ACTH treatment of multiple sclerosis].
Boman K; Hokkanen E; Jarho L; Kivalo E
Duodecim; 1966; 82(18):867-73. PubMed ID: 4288673
[No Abstract] [Full Text] [Related]
11. [Therapy of multiple sclerosis].
Kesselring J
Schweiz Med Wochenschr; 1984 Sep; 114(35):1186-90. PubMed ID: 6091263
[TBL] [Abstract][Full Text] [Related]
12. Arterio-venous disorders influenced centrally with Mydocalm.
Fric M; Kozák P; Martinek J; Wimmer P
Ther Hung; 1974; 22(3):108-11. PubMed ID: 4445978
[No Abstract] [Full Text] [Related]
13. [Relaxation-promoting effect of vitamin B with anabolics].
Husemann F; Kugler J; Frank I
Arzneimittelforschung; 1970 Apr; 20(4):557-60. PubMed ID: 4246146
[No Abstract] [Full Text] [Related]
14. Medications used in the treatment of multiple sclerosis.
Schapiro RT
Phys Med Rehabil Clin N Am; 1999 May; 10(2):437-46, ix. PubMed ID: 10370939
[TBL] [Abstract][Full Text] [Related]
15. [Modern views on the treatment of multiple sclerosis].
Sieniarski A
Wiad Lek; 1974 Feb; 27(4):337-40. PubMed ID: 4360561
[No Abstract] [Full Text] [Related]
16. Current medical treatment of multiple sclerosis.
Alter M
Clin Ther; 1983; 5(5):455-60. PubMed ID: 6193881
[No Abstract] [Full Text] [Related]
17. [Facial paralysis].
Peña J; León N; Martínez M
Rev Neurol; 1995; 23 Suppl 3():S318-21. PubMed ID: 7497306
[No Abstract] [Full Text] [Related]
18. Treatment and prevention of myelin disorders: multiple sclerosis.
Abramsky O
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
[No Abstract] [Full Text] [Related]
19. [Results of the treatment of multiple sclerosis with sulfurated oil and bibazol].
GEORGIEV I; IORDANOV B
Suvr Med (Sofiia); 1957; 8(3):49-53. PubMed ID: 13506912
[No Abstract] [Full Text] [Related]
20. [Tolperisone in spasticity and muscle spasm. Tolperisone in multiple sclerosis].
Nervenarzt; 1996 Jul; 67(7 Suppl Tolperison):1-4. PubMed ID: 9404528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
